Aurora Cannabis (TSE:ACB) Reaches New 12-Month Low – Here’s Why

Shares of Aurora Cannabis Inc. (TSE:ACB) hit a new 52-week low during trading on Friday . The company traded as low as C$4.48 and last traded at C$4.48, with a volume of 191146 shares trading hands. The stock had previously closed at C$4.65.

Wall Street Analysts Forecast Growth

A number of research analysts recently weighed in on ACB shares. ATB Cormark Capital Markets reduced their price objective on shares of Aurora Cannabis from C$9.00 to C$8.50 and set an “outperform” rating for the company in a research note on Thursday, December 11th. Canaccord Genuity Group set a C$10.00 target price on Aurora Cannabis and gave the stock a “buy” rating in a research report on Tuesday, January 27th. Two analysts have rated the stock with a Buy rating, According to MarketBeat.com, Aurora Cannabis currently has a consensus rating of “Buy” and a consensus target price of C$9.25.

Aurora Cannabis Stock Down 3.0%

The stock’s fifty day moving average is C$5.20 and its two-hundred day moving average is C$6.23. The company has a current ratio of 3.06, a quick ratio of 2.48 and a debt-to-equity ratio of 25.02. The firm has a market cap of C$255.76 million, a P/E ratio of -3.01 and a beta of 0.26.

About Aurora Cannabis

Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael ’71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.